Canine Pai 1 Recombinant Wild Type Latent

• Description:

  Canine Pai 1 Recombinant Wild Type Latent_x000D_ Catalog number: B2017120_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 100 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -80C_x000D_ Keywords: Canine Pai 1 Recombinant Wild Type Latent_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Credo RB, Burke SE. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):8S-18S._x000D_ 2: Jurič R, Vidmar G, Blagus R, Jan J. Factors associated with the outcome of root canal treatment-A cohort study conducted in a private practice Int Endod J. 2024 Apr;57(4):377-393._x000D_ 3: Gaudette S, Smart L, Woodward AP, Sharp CR, Hughes D, Bailey SR, Dandrieux JRS, Santos L, Boller M. Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis Front Vet Sci. 2023 Jul 13;10:1127099._x000D_ 4: Asakura M, Takashima S, Asano Y, Honma T, Asanuma H, Sanada S, Shintani Y, Liao Y, Kim J, Ogita H, Node K, Minamino T, Yorikane R, Agai A, Kitamura S, Tomoike H, Hori M, Kitakaze M. Canine DNA array as a potential tool for combining physiology and molecular biology Circ J. 2003 Sep;67(9):788-92._x000D_ 5: Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology Circ Res. 2001 May 25;88(10):987-97._x000D_ 6: Cai W, Vosschulte R, Afsah-Hedjri A, Koltai S, Kocsis E, Scholz D, Kostin S, Schaper W, Schaper J. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis J Mol Cell Cardiol. 2000 Jun;32(6):997-1011._x000D_ 7: Miyazaki H, Ogiku T, Sai H, Ohmizu H, Murakami J, Ohtani A. Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production Bioorg Med Chem Lett. 2008 Dec 15;18(24):6419-22._x000D_ 8: Han W, Li WM, Song LY, Li Y, Yang SS, Huang YL, Gan RT, Kou JJ, Geng JQ. [The experimental study on changes of endothelial nitric oxide synthase and plasminogen activator inhibitor-1 protein in the canine atrial fibrillation model] Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Jan;33(1):69-72._x000D_ 9: Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J. Remodeling of the adventitia during coronary arteriogenesis Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H31-40._x000D_ 10: Yan H, Mao Q, Ma Y, Wang L, Chen X, Hu Y, Ge H. Seawater Immersion Aggravates Burn Injury Causing Severe Blood Coagulation Dysfunction Biomed Res Int. 2016;2016:9471478. _x000D_ _x000D_ Products Related to Canine Pai 1 Recombinant Wild Type Latent can be found at Proteins

• Short Description:

  Catalog Number: B2017120 (100 ug)_x000D_ Canine Pai 1 Recombinant Wild Type Latent is a high quality protein that is derived from the canine species. It is a recombinant form of the wild type latent form of the Pai 1 protein. This protein is involved in regulating blood clotting and is important for maintaining the balance between clot formation and clot breakdown in the body. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3